A long-term, non comparative, multi-centre study to further evaluate the response to treatment and safety of 0.03% Tacrolimus (FK 506) ointment administered in paediatric patients with moderate to severe atopic dermatitis
DEC-NET Serial number IT465
Published online12/09/2005 11.51.00
Last updated12/09/2005 11.52.51
Other protocol ID number
Current trial status
Major Disease
(ICD9 class)		Atopic dermatitis and related conditions
Experimental drug
TACROLIMUS
GenderBoth
Age (range)2-15 years

Eligibility criteria

Trial design/methodology
Phase3
Kind of study
Design
Principal investigator
NameProf. Mauro Paradisi
InstitutionIDI . Divisione di Dermatologia Pediatrica
Postal addressVia dei Monti di Creta, 104 - 00167
CityRoma
CountryITALY
Phone
Fax
E-mail


Promoter
Fujisawa GmbH (Industry)

ISRCTN  EudraCT